# 510(k) SUBSTANTIAL EQUIVALENCE DETERMINATION DECISION SUMMARY ASSAY ONLY

I Background Information:

# B Applicant

Shenzhen Bioeasy Biotechnology Co.,Ltd.

# C Proprietary and Established Names

BIOEASY Multi-Drug Test Cup

# D Regulatory Information

<table><tr><td colspan="1" rowspan="1">Product Code</td><td colspan="1" rowspan="1">Classification</td><td colspan="1" rowspan="1">Regulation Section</td><td colspan="1" rowspan="1">Panel</td></tr><tr><td colspan="1" rowspan="1">NFTAmphetamine</td><td colspan="1" rowspan="1">II</td><td colspan="1" rowspan="1">21 CFR § 862.3100, AmphetamineTest System</td><td colspan="1" rowspan="1">Toxicology (91)</td></tr><tr><td colspan="1" rowspan="1">NFWCannabinoids</td><td colspan="1" rowspan="1">I</td><td colspan="1" rowspan="1">21 CFR § 862.3870, CannabinoidsTest System</td><td colspan="1" rowspan="1">Toxicology (91)</td></tr><tr><td colspan="1" rowspan="1">NFYCocaine</td><td colspan="1" rowspan="1">Ⅱ</td><td colspan="1" rowspan="1">21 CFR § 862.3250, Cocaine andCocaine Metabolites Test System</td><td colspan="1" rowspan="1">Toxicology (91)</td></tr><tr><td colspan="1" rowspan="1">NGGMethamphetamine</td><td colspan="1" rowspan="1">Ⅱ</td><td colspan="1" rowspan="1">21 CFR § 862.3610,Methamphetamine Test System</td><td colspan="1" rowspan="1">Toxicology (91)</td></tr><tr><td colspan="1" rowspan="1">NGIMorphine</td><td colspan="1" rowspan="1">Ⅱ</td><td colspan="1" rowspan="1">21 CFR § 862.3640, MorphineTest System</td><td colspan="1" rowspan="1">Toxicology (91)</td></tr><tr><td colspan="1" rowspan="1">NFVOxazepam</td><td colspan="1" rowspan="1">I</td><td colspan="1" rowspan="1">21 CFR § 862.3170,Benzodiazepine Test System</td><td colspan="1" rowspan="1">Toxicology (91)</td></tr><tr><td colspan="1" rowspan="1">NGLOxycodone</td><td colspan="1" rowspan="1">I</td><td colspan="1" rowspan="1">21 CFR § 862.3650, Opiate TestSystem</td><td colspan="1" rowspan="1">Toxicology (91)</td></tr><tr><td colspan="1" rowspan="1">PTHSecobarbital</td><td colspan="1" rowspan="1">Ⅱ</td><td colspan="1" rowspan="1">21 CFR § 862.3150, BarbiturateTest System</td><td colspan="1" rowspan="1">Toxicology (91)</td></tr><tr><td colspan="1" rowspan="1">NGLBuprenorphine</td><td colspan="1" rowspan="1">Ⅱ</td><td colspan="1" rowspan="1">21 CFR § 862.3650,Opiate Test System</td><td colspan="1" rowspan="1">Toxicology (91)</td></tr><tr><td colspan="1" rowspan="1">NGGMethylenedioxy-methamphetamine</td><td colspan="1" rowspan="1">Ⅱ</td><td colspan="1" rowspan="1">21 CFR § 862.3610,Methamphetamine Test System</td><td colspan="1" rowspan="1">Toxicology (91)</td></tr><tr><td colspan="1" rowspan="1">NGMPhencyclidine</td><td colspan="1" rowspan="1">unclassified</td><td colspan="1" rowspan="1">Enzyme ImmunoassayPhencyclidine</td><td colspan="1" rowspan="1">Toxicology (91)</td></tr><tr><td colspan="1" rowspan="1">PTGMethadone</td><td colspan="1" rowspan="1">Ⅱ</td><td colspan="1" rowspan="1">21 CFR § 862.3620, MethadoneTest System</td><td colspan="1" rowspan="1">Toxicology (91)</td></tr><tr><td colspan="1" rowspan="1">QAWNortriptyline</td><td colspan="1" rowspan="1">Ⅱ</td><td colspan="1" rowspan="1">21 CFR, 862.3910 TricyclicAntidepressant Drugs Test System</td><td colspan="1" rowspan="1">Toxicology (91)</td></tr><tr><td colspan="1" rowspan="1">QBFPropoxyphene</td><td colspan="1" rowspan="1">Ⅱ</td><td colspan="1" rowspan="1">21 CFR, 862.3700 PropoxypheneTest System</td><td colspan="1" rowspan="1">Toxicology (91)</td></tr></table>

# II Submission/Device Overview:

A Purpose for Submission:

Modification of a previously cleared device (k182530) to add a Morphine $2 0 0 0 ~ \mathrm { n g / m L }$ ) test strip.

# B Measurand:

Morphine, Amphetamine, Oxazepam, Cocaine, Marijuana, Methamphetamine. Oxycodone, Secobarbital, Buprenorphine, Methylenedioxy-methamphetamine, Phencyclidine, Methadone, Nortriptyline, d-Propoxyphene.

# C Type of Test:

Qualitative, immunochromatographic assay

# III Intended Use/Indications for Use:

A Intended Use(s): See Indications for Use below.

# B Indication(s) for Use:

BIOEASY Multi-Drug Test Cup Tests are competitive binding, lateral flow immunochromatographic assays for qualitative ad simultaneous detection of Amphetamine, Oxazepam, Cocaine, Marijuana, Methamphetamine, Morphine, Oxycodone, Secobarbital, Buprenorphine, Methylenedioxy-methamphetamine, Phencyclidine, Methadone, Nortriptyline and d-Propoxyphene in human urine at the cutoff concentrations of:

Drug Identifier Cut-off Level Amphetamine 1000 ng/mL Oxazepam 300 ng/mL

Cocaine 300 ng/mL   
Marijuana 50 ng/mL   
Methamphetamine 1000 ng/mL   
Morphine $3 0 0 ~ \mathrm { { n g / m L } }$ or $2 0 0 0 ~ \mathrm { { n g / m L } }$   
Oxycodone $\begin{array} { c } { { 1 0 0 \mathrm { n g / m L } } } \\ { { } } \\ { { 3 0 0 \mathrm { n g / m L } } } \\ { { } } \\ { { 1 0 \mathrm { n g / m L } } } \end{array}$   
Secobarbital   
Buprenorphine

Methylenedioxy-methamphetamine $5 0 0 ~ \mathrm { { n g / m L } }$

Phencyclidine 25 ng/mL Methadone 300 ng/mL Nortriptyline 1000 ng/mL d-Propoxyphene 300 ng/mL

Configuration of the BIOEASY Multi-Drug Test Cup tests can consist of any combination of the above listed drug analytes.

The test may yield positive results for the prescription drugs Buprenorphine, Nortriptyline, Oxazepam, Secobarbital, Propoxyphene and Oxycodone when taken at or above prescribed doses. It is not intended to distinguish between prescription use or abuse of these drugs. Clinical consideration and professional judgment should be exercised with any drug of abuse test result, particularly when the preliminary result is positive. The test provides only preliminary test results. A more specific alternative chemical method must be used in order to obtain a confirmed analytical result. GC/MS or LC/MS is the preferred confirmatory method.

For in vitro diagnostic use only.

C Special Conditions for Use Statement(s): OTC - Over The Counter For in vitro diagnostic use only.   
D Special Instrument Requirements: None. This is an assay only device.

IV Device/System Characteristics:

A Device Description:

The BIOEASY Multi-Drug Test Cup tests are immunochromatographic assays that use a lateral flow system for the qualitative detection of Amphetamine, Oxazepam, Cocaine, Marijuana, Methamphetamine, Morphine, Oxycodone, Secobarbital, Buprenorphine, Methylenedioxymethamphetamine, Phencyclidine, Methadone, Nortriptyline and Propoxyphene (target analytes) in human urine. The products are single-use in vitro diagnostic devices. Each test kit contains a Test Device, a package insert and a urine cup for sample collection. Each test device is sealed with a desiccant in an aluminum pouch.

# B Principle of Operation:

The BIOEASY Multi-Drug Test Cup tests are rapid tests for the qualitative detection of Amphetamine, Oxazepam, Cocaine, Marijuana, Methamphetamine, Morphine, Oxycodone, Secobarbital, Buprenorphine, Methylenedioxy-methamphetamine, Phencyclidine, Methadone, Nortriptyline and Propoxyphene in urine samples. The tests are lateral flow chromatographic immunoassays. During testing, a urine specimen migrates upward by capillary action. If target drugs present in the urine specimen are below the cut-off concentration, it will not saturate the binding sites of its specific monoclonal mouse antibody coated on the particles. The antibodycoated particles will then be captured by immobilized drug-conjugate and a visible colored line will show up in the test line region. The colored line will not form in the test line region if the target drug level exceeds its cutoff-concentration because it will saturate all the binding sites of the antibody coated on the particles. A band should form in the control region of the devices regardless of the presence of drug or metabolite in the sample to indicate that the tests have been performed properly.

# V Substantial Equivalence Information:

A Predicate Device Name(s): BIOEASY Multi-Drug Test Cup B Predicate 510(k) Number(s): K182530

C Comparison with Predicate(s):

<table><tr><td colspan="1" rowspan="1">Device &amp; PredicateDevice(s):</td><td colspan="1" rowspan="1">K193480</td><td colspan="1" rowspan="1">K182530</td></tr><tr><td colspan="1" rowspan="1">Device Trade Name</td><td colspan="1" rowspan="1">BIOEASY Multi-Drug Test Cup</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">General DeviceCharacteristic Similarities</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Intended Use/IndicationsFor Use</td><td colspan="1" rowspan="1">For the qualitative determination ofdrugs of abuse in human urine.</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Calibrator and Cut-offValues</td><td colspan="1" rowspan="1">Amphetamine (AMP): 1000 ng/mLOxazepam (BZO): 300 ng/mLCocaine (COC): 300 ng/mLMarijuana (THC): 50 ng/mLMethamphetamine (MET): 1000 ng/mLMorphine (MOR): 300 ng/mL</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1">Oxycodone (OXY): 100 ng/mLSecobarbital (BAR): 300 ng/mLBuprenorphine (BUP): 10 ng/mLMethylenedioxy-methamphetamine(MDMA): 500 ng/mLPhencyclidine (PCP): 25 ng/mLMethadone (MTD): 300 ng/mLNortriptyline (TCA): 1000 ng/mLPropoxyphene (PPX): 300 ng/mL</td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Test Methodology</td><td colspan="1" rowspan="1">Competitive binding, lateral flowimmunochromatographic assays basedon the principle of antigen antibodyimmunochemistry.</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Test Type</td><td colspan="1" rowspan="1">Qualitative</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Specimen Type</td><td colspan="1" rowspan="1">Human Urine</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Intended Use</td><td colspan="1" rowspan="1">For over-the-counter use</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">Configurations</td><td colspan="1" rowspan="1">Cup format</td><td colspan="1" rowspan="1">Same</td></tr><tr><td colspan="1" rowspan="1">General DeviceCharacteristic Differences</td><td colspan="1" rowspan="1"></td><td colspan="1" rowspan="1"></td></tr><tr><td colspan="1" rowspan="1">Calibrator and Cut-offValues</td><td colspan="1" rowspan="1">Morphine (MOR):300 ng/mL or 2000 ng/mL</td><td colspan="1" rowspan="1">Morphine (MOR):300 ng/mL</td></tr></table>

# VI Standards/Guidance Documents Referenced:

None identified.

VII Performance Characteristics (if/when applicable):

# A Analytical Performance:

1. Precision/Reproducibility:

Combined precision and cutoff studies were carried out using samples at the analyte concentrations: $- 1 0 0 \%$ cutoff, $- 7 5 \%$ cutoff, $- 5 0 \%$ cutoff, $- 2 5 \%$ cutoff, cutoff, $+ 2 5 \%$ cutoff, $+ 5 0 \%$ cutoff, $+ 7 5 \%$ cutoff and $+ 1 0 0 \%$ cutoff of Morphine $2 0 0 0 ~ \mathrm { { n g / m L } }$ . These samples were prepared by spiking morphine in negative urine samples to achieve final concentration of $4 0 8 0 ~ \mathrm { { n g / m L } }$ , $3 5 6 0 ~ \mathrm { n g / m L }$ , $3 0 6 5 ~ \mathrm { n g / m L }$ , $2 4 6 5 ~ \mathrm { n g / m L }$ , $2 0 2 5 ~ \mathrm { n g / m L }$ , $1 4 8 0 ~ \mathrm { n g / m L }$ , $9 7 0 ~ \mathrm { { n g / m L } }$ , $4 5 5 ~ \mathrm { { n g / m L } }$ and $0 \mathrm { n g / m L }$ morphine as measured by LC/MS. All sample aliquots were blinded and labeled by the person who prepared the samples and did not participate in sample testing. Each sample was tested by three operators in two runs per day for 25 days per device lot in a randomized order using three lots of the candidate device. The results obtained are summarized in the following table for morphine $2 0 0 0 ~ \mathrm { { n g / m L } }$ . The precision data for Amphetamine, Oxazepam, Cocaine, Marijuana, Methamphetamine, Morphine (300), Oxycodone, Secobarbital, Buprenorphine, Methylenedioxy-methamphetamine,

Phencyclidine, Methadone, Nortriptyline and Propoxyphene were previously reported in k182530.

Morphine $2 0 0 0 ~ \mathrm { { n g / m L } }$   

<table><tr><td rowspan=1 colspan=1>LotNumber</td><td rowspan=1 colspan=1>-100%cut off</td><td rowspan=1 colspan=1>-75%cut off</td><td rowspan=1 colspan=1>-50%cut off</td><td rowspan=1 colspan=1>-25%cutoff</td><td rowspan=1 colspan=1>cut off</td><td rowspan=1 colspan=1>+25%cut off</td><td rowspan=1 colspan=1>+50%cut off</td><td rowspan=1 colspan=1>+75%cut off</td><td rowspan=1 colspan=1>+100%cut off</td></tr><tr><td rowspan=1 colspan=1>Lot 1</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>26-/24+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 2</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>29-/21+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr><tr><td rowspan=1 colspan=1>Lot 3</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>50-/0+</td><td rowspan=1 colspan=1>24-/26+</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td><td rowspan=1 colspan=1>50+/0-</td></tr></table>

2. Linearity:

Not applicable, these devices are intended for qualitative use only.

3. Analytical Specificity/Interference:

Interference Studies:

Potential interfering substances found in human urine of physiological or pathological conditions were added to drug-free urine and urine with concentrations at $2 5 \%$ below (morphine $1 5 0 0 ~ \mathrm { n g / m L } )$ and $2 5 \%$ above (morphine $2 5 0 0 ~ \mathrm { { n g / m L } }$ the cutoff level of 2000 $\mathrm { n g / m L }$ morphine. These urine samples were tested using three lots of the device by three operators. Compounds that showed no interference at a concentration of $1 0 0 ~ \mu \mathrm { g / m L }$ (albumin was tested at $1 0 0 \mathrm { m g / d L }$ , ethanol at $1 \%$ , bilirubin at $5 0 0 ~ \mu \mathrm { g / m L }$ ) are summarized in the following tables. The interferences data for Amphetamine, Oxazepam, Cocaine, Marijuana, Methamphetamine, Morphine (300), Oxycodone, Secobarbital, Buprenorphine, Methylenedioxy-methamphetamine, Phencyclidine, Methadone, Nortriptyline and Propoxyphene were previously reported in k182530.

<table><tr><td colspan="1" rowspan="1">Acetaminophen</td><td colspan="1" rowspan="1">β-Estradiol</td><td colspan="1" rowspan="1">Oxalic acid</td></tr><tr><td colspan="1" rowspan="1">Acetophenetidin</td><td colspan="1" rowspan="1">Erythromycin</td><td colspan="1" rowspan="1">Oxolinic acid</td></tr><tr><td colspan="1" rowspan="1">N-Acetylprocainamide</td><td colspan="1" rowspan="1">Ethanol</td><td colspan="1" rowspan="1">Oxymetazoline</td></tr><tr><td colspan="1" rowspan="1">Acetylsalicylic acid</td><td colspan="1" rowspan="1">Fenoprofen</td><td colspan="1" rowspan="1">Papaverine</td></tr><tr><td colspan="1" rowspan="1">Albumin (100 mg/dL)</td><td colspan="1" rowspan="1">Furosemide</td><td colspan="1" rowspan="1">Penicillin G</td></tr><tr><td colspan="1" rowspan="1">Aminopyrine</td><td colspan="1" rowspan="1">Gentisic acid</td><td colspan="1" rowspan="1">Perphenazine</td></tr><tr><td colspan="1" rowspan="1">Amoxicillin</td><td colspan="1" rowspan="1">Hemoglobin</td><td colspan="1" rowspan="1">Phenelzine</td></tr><tr><td colspan="1" rowspan="1">Ampicillin</td><td colspan="1" rowspan="1">Hydralazine</td><td colspan="1" rowspan="1">Prednisone</td></tr><tr><td colspan="1" rowspan="1">Apomorphine</td><td colspan="1" rowspan="1">Hydrochlorothiazide</td><td colspan="1" rowspan="1">(±)-Propranolol</td></tr><tr><td colspan="1" rowspan="1">Ascorbic acid</td><td colspan="1" rowspan="1">Hydrocortisone</td><td colspan="1" rowspan="1">Pseudoephedrine</td></tr><tr><td colspan="1" rowspan="1">Aspartame</td><td colspan="1" rowspan="1">O-Hydroxyhippuric acid</td><td colspan="1" rowspan="1">Quinine</td></tr><tr><td colspan="1" rowspan="1">Atropine</td><td colspan="1" rowspan="1">3-Hydroxytyramine</td><td colspan="1" rowspan="1">Ranitidine</td></tr><tr><td colspan="1" rowspan="1">Benzilic acid</td><td colspan="1" rowspan="1">Ibuprofen</td><td colspan="1" rowspan="1">Salicylic acid</td></tr><tr><td colspan="1" rowspan="1">Benzoic acid</td><td colspan="1" rowspan="1">Isoproterenol</td><td colspan="1" rowspan="1">Serotonin (5- Hydroxytyramine)</td></tr><tr><td colspan="1" rowspan="1">Bilirubin</td><td colspan="1" rowspan="1">Isoxsuprine</td><td colspan="1" rowspan="1">Sulfamethazine</td></tr><tr><td colspan="1" rowspan="1">Chloral hydrate</td><td colspan="1" rowspan="1">Ketamine</td><td colspan="1" rowspan="1">Sulindac</td></tr><tr><td colspan="1" rowspan="1">Chloramphenicol</td><td colspan="1" rowspan="1">Ketoprofen</td><td colspan="1" rowspan="1">Tetrahydrocortisone 3-(β-Dglucuronide)</td></tr><tr><td colspan="1" rowspan="1">Chlorothiazide</td><td colspan="1" rowspan="1">Labetalol</td><td colspan="1" rowspan="1">Tetrahydrocortisone 3-acetate</td></tr><tr><td colspan="1" rowspan="1">Chlorpromazine</td><td colspan="1" rowspan="1">Loperamide</td><td colspan="1" rowspan="1">Tetrahydrozoline</td></tr><tr><td colspan="1" rowspan="1">Cholesterol</td><td colspan="1" rowspan="1">Meperidine</td><td colspan="1" rowspan="1">Thiamine</td></tr><tr><td colspan="1" rowspan="1">Clonidine</td><td colspan="1" rowspan="1">Meprobamate</td><td colspan="1" rowspan="1">Thioridazine</td></tr><tr><td colspan="1" rowspan="1">Cortisone</td><td colspan="1" rowspan="1">Methoxyphenamine</td><td colspan="1" rowspan="1">Triamterene</td></tr><tr><td colspan="1" rowspan="1">(-)-Cotinine</td><td colspan="1" rowspan="1">Nalidixic acid</td><td colspan="1" rowspan="1">Trifluoperazine</td></tr><tr><td colspan="1" rowspan="1">Creatinine</td><td colspan="1" rowspan="1">Naloxone</td><td colspan="1" rowspan="1">Trimethoprim</td></tr><tr><td colspan="1" rowspan="1">Deoxycorticosterone</td><td colspan="1" rowspan="1">Naltrexone</td><td colspan="1" rowspan="1">DL-Tryptophan</td></tr><tr><td colspan="1" rowspan="1">Dextromethorphan</td><td colspan="1" rowspan="1">Naproxen</td><td colspan="1" rowspan="1">Tyramine</td></tr><tr><td colspan="1" rowspan="1">Diclofenac</td><td colspan="1" rowspan="1">Niacinamide</td><td colspan="1" rowspan="1">DL-Tyrosine</td></tr><tr><td colspan="1" rowspan="1">Diflunisal</td><td colspan="1" rowspan="1">Nifedipine</td><td colspan="1" rowspan="1">Uric acid</td></tr><tr><td colspan="1" rowspan="1">Digoxin</td><td colspan="1" rowspan="1">Norethindrone</td><td colspan="1" rowspan="1">Verapamil</td></tr><tr><td colspan="1" rowspan="1">Diphenhydramine</td><td colspan="1" rowspan="1">Noscapine</td><td colspan="1" rowspan="1">Zomepirac</td></tr><tr><td colspan="1" rowspan="1">Ecgonine methyl ester</td><td colspan="1" rowspan="1">(±)-Octopamine</td><td colspan="1" rowspan="1">EY</td></tr></table>

# Cross-Reactivity Studies:

Cross-reactivity studies were performed to determine whether the drug metabolites of morphine or structurally related drugs cross-react with the candidate device. These compounds added at $1 0 0 ~ \mu \mathrm { g / m L }$ concentration in pooled negative human urine samples. Compounds that tested positive were serially diluted until a negative result was observed. The minimum concentration of each compound producing a positive result is shown in the table below. The cross-reactivity data for Amphetamine, Oxazepam, Cocaine, Marijuana, Methamphetamine, Morphine (300), Oxycodone, Secobarbital, Buprenorphine, Methylenedioxy-methamphetamine, Phencyclidine, Methadone, Nortriptyline and Propoxyphene were reported in k182530.

<table><tr><td rowspan=1 colspan=1>Opiate(Morphine, Cut-off=2000 ng/mL)</td><td rowspan=1 colspan=1>Result</td><td rowspan=1 colspan=1>%Cross-Reactivity</td></tr><tr><td rowspan=1 colspan=1>Morphine</td><td rowspan=1 colspan=1>Positive at 2000 ng/mL</td><td rowspan=1 colspan=1>100%</td></tr><tr><td rowspan=1 colspan=1>Codeine</td><td rowspan=1 colspan=1>Positive at 200 ng/mL</td><td rowspan=1 colspan=1>1000%</td></tr><tr><td rowspan=1 colspan=1>Ethylmorphine</td><td rowspan=1 colspan=1>Positive at 2500ng/mL</td><td rowspan=1 colspan=1>80%</td></tr><tr><td rowspan=1 colspan=1>Hydrocodone</td><td rowspan=1 colspan=1>Negative at 100000 ng/mL</td><td rowspan=1 colspan=1>&lt;2%</td></tr><tr><td rowspan=1 colspan=1>Hydromorphone</td><td rowspan=1 colspan=1>Positive at 4000 ng/mL</td><td rowspan=1 colspan=1>50%</td></tr><tr><td rowspan=1 colspan=1>Levorphanol</td><td rowspan=1 colspan=1>Negative at 100000 ng/mL</td><td rowspan=1 colspan=1>&lt;2%</td></tr><tr><td rowspan=1 colspan=1>6-Acetylmorphine</td><td rowspan=1 colspan=1>Positive at 3000_ng/mL</td><td rowspan=1 colspan=1>67%</td></tr><tr><td rowspan=1 colspan=1>Morphine-3-β-D-glucuronide</td><td rowspan=1 colspan=1>Positive at 6000 ng/mL</td><td rowspan=1 colspan=1>33%</td></tr><tr><td rowspan=1 colspan=1>Normorphine</td><td rowspan=1 colspan=1>Negative at 100000 ng/mL</td><td rowspan=1 colspan=1>&lt;2%</td></tr><tr><td rowspan=1 colspan=1>Oxycodone</td><td rowspan=1 colspan=1>Negative at 100000 ng/mL</td><td rowspan=1 colspan=1>&lt;2%</td></tr><tr><td rowspan=1 colspan=1>Oxymorphone</td><td rowspan=1 colspan=1>Negative at 100000 ng/mL</td><td rowspan=1 colspan=1>&lt;2%</td></tr><tr><td rowspan=1 colspan=1>Procaine</td><td rowspan=1 colspan=1>Negative at 100000 ng/mL</td><td rowspan=1 colspan=1>&lt;2%</td></tr><tr><td rowspan=1 colspan=1>Thebaine</td><td rowspan=1 colspan=1>Negative at 100000_ng/mL</td><td rowspan=1 colspan=1>&lt;2%</td></tr><tr><td rowspan=1 colspan=1>Heroin</td><td rowspan=1 colspan=1>Positive at 3500 ng/mL</td><td rowspan=1 colspan=1>57%</td></tr></table>

Effect of Urine Specific Gravity and Urine pH:

To investigate the effect of urine specific gravity and urine $\mathsf { p H }$ , urine samples, with 1.000 to 1.035 specific gravity or urine samples with $\mathrm { p H } 4$ to 9 were spiked with morphine at $2 5 \%$ below (morphine $1 5 0 0 ~ \mathrm { n g / m L ) }$ ) and $2 5 \%$ above (morphine $2 5 0 0 ~ \mathrm { { n g / m L } }$ ) the cutoff of 2000 $\mathrm { n g / m L }$ . These samples were tested by three operators using three lots of the candidate device. For all lots tested, results were all positive for samples at and above $+ 2 5 \%$ cutoff and all negative for samples below $- 2 5 \%$ cutoff. The data for Amphetamine, Oxazepam, Cocaine, Marijuana, Methamphetamine, Morphine (300), Oxycodone, Secobarbital, Buprenorphine, Methylenedioxy-methamphetamine, Phencyclidine, Methadone, Nortriptyline and Propoxyphene were previously reported in k182530.

4. Assay Reportable Range: Not applicable.

5. Traceability, Stability, Expected Values (Controls, Calibrators, or Methods):

The stability study protocols and acceptance criteria were reviewed and found to be acceptable. The candidate device is stable at $4 { } ^ { \circ } \mathrm { C } - 3 0 { } ^ { \circ } \mathrm { C }$ for 24 months based on the real time stability studies at both $4 ^ { \circ } \mathrm { C }$ and $3 0 ~ ^ { \circ } \mathrm { C }$ . A transport simulation study was conducted to demonstrate that the candidate device is stable at the conditions of $4 0 ~ ^ { \circ } \mathrm { C }$ and ${ } - 2 0 \ { } ^ { \circ } \mathrm { C }$ for up to 35 days.

6. Detection Limit: Not applicable.

7. Assay Cut-Off: See section VII.A.1.

# B Comparison Studies:

1. Method Comparison with Predicate Device:

A method comparison study for the BOEASY Multi-Drug Test Cup Morphine $( 2 0 0 0 ~ \mathrm { n g / m L } )$ test strip was conducted in-house by three laboratory personnel using one lot of the candidate device. Each of the three operators tested 80 (40 negative and 40 positive) unaltered clinical samples. The samples were blind-labeled and randomized by a laboratory personnel who does not participate in sample testing. The candidate device results were compared to results obtained by LC/MS. The study results are summarized in the below. The accuracy data for Amphetamine, Oxazepam, Cocaine, Marijuana, Methamphetamine, Morphine (300), Oxycodone, Secobarbital, Buprenorphine, Methylenedioxy-methamphetamine, Phencyclidine, Methadone, Nortriptyline and Propoxyphene were reported in k182530.

Morphine $2 0 0 0 ~ \mathrm { { n g / m L } }$

<table><tr><td rowspan=1 colspan=1>b</td><td rowspan=1 colspan=1></td><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>LowNegative byLC/MS(less than-50%)</td><td rowspan=1 colspan=1>Near CutoffNegative byLC/MS(Between-50% andcutoff)</td><td rowspan=1 colspan=1>Near CutoffPositive byLC/MS(Between thecutoff and+50%</td><td rowspan=1 colspan=1>High Positiveby LC/MS(greater than+50%)</td></tr><tr><td rowspan=2 colspan=1>ViewerA</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>18</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerB</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>18</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr><tr><td rowspan=2 colspan=1>ViewerC</td><td rowspan=1 colspan=1>Positive</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>21</td><td rowspan=1 colspan=1>18</td></tr><tr><td rowspan=1 colspan=1>Negative</td><td rowspan=1 colspan=1>7</td><td rowspan=1 colspan=1>15</td><td rowspan=1 colspan=1>16</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>0</td></tr></table>

Discordant Results for Morphine $2 0 0 0 ~ \mathrm { { n g / m L } }$   

<table><tr><td rowspan=1 colspan=1>Viewer</td><td rowspan=1 colspan=1>Sample Number</td><td rowspan=1 colspan=1>LC/MS Result</td><td rowspan=1 colspan=1>BIOEASY CupViewer Results</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>OPIC341</td><td rowspan=1 colspan=1>1920</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>OPIC335</td><td rowspan=1 colspan=1>1870</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>OPIC450</td><td rowspan=1 colspan=1>1860</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>OPIC335</td><td rowspan=1 colspan=1>1870</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>OPIC341</td><td rowspan=1 colspan=1>1920</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>OPIC450</td><td rowspan=1 colspan=1>1860</td><td rowspan=1 colspan=1>Positive</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>OPIC475</td><td rowspan=1 colspan=1>2150</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer A</td><td rowspan=1 colspan=1>OPIC408</td><td rowspan=1 colspan=1>2100</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer B</td><td rowspan=1 colspan=1>OPIC408</td><td rowspan=1 colspan=1>2100</td><td rowspan=1 colspan=1>Negative</td></tr><tr><td rowspan=1 colspan=1>Viewer C</td><td rowspan=1 colspan=1>OPIC475</td><td rowspan=1 colspan=1>2150</td><td rowspan=1 colspan=1>Negative</td></tr></table>

Lay user study:

A lay user study was conducted at three intended user sites by 300 lay users using three lots of the candidate device. The lay users had diverse educational and professional backgrounds. Urine samples were prepared by spiking amphetamine, oxazepam, cocaine, marijuana, methamphetamine, morphine, oxycodone, secobarbital, buprenorphine, methylenedioxymethamphetamine, phencyclidine, methadone, nortriptyline and propoxyphene at various concentrations (negative, $+ / - 7 5 \%$ , $+ / - 5 0 \%$ , $+ / - 2 5 \%$ of the cutoff) into 23 drug-free urine sample pools. The concentration of the drugs in these samples were confirmed by LC/MS/MS. Each sample was aliquoted into individual containers and blind-labeled by a lab personnel who did not participate in sample testing. Each lay user participant was provided with the package insert, one blind labeled sample and a candidate device, with no training to test the sample. The results are summarized in the below table.

The summary result for Amphetamine

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberof samples</td><td rowspan=2 colspan=1>Drug Concentrationby LC/MS/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay person Results</td><td rowspan=2 colspan=1>The percentageof correctresults (%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>261</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50%Cutoff</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>507</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>771</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1290</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+50% Cutoff</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>1560</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1870</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

The summary result for Secobarbital

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>Drug Concentrationby LC/MS/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay person Results</td><td rowspan=2 colspan=1>The percentageof correctresults (%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>75.9</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>220</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>360</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+50% Cutoff</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>429</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>501</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

The summary result for Cocaine   

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>Drug Concentrationby LC/MS/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay person Results</td><td rowspan=2 colspan=1>The percentageof correctresults (%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>81.5</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>151</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>225</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>395</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+50% Cutoff</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>455</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>520</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

The results summary for Buprenorphine   

<table><tr><td colspan="1" rowspan="2">% of Cutoff</td><td colspan="1" rowspan="2">Numberofsamples</td><td colspan="1" rowspan="2">Drug Concentrationby LC/MS/MS(ng/mL)</td><td colspan="2" rowspan="1">Lay person Results</td><td colspan="1" rowspan="2">The percentageof correctresults (%)</td></tr><tr><td colspan="1" rowspan="1">No. ofPositive</td><td colspan="1" rowspan="1">No. ofNegative</td></tr><tr><td colspan="1" rowspan="1">-100% Cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-75% Cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">2.57</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-50% Cutoff</td><td colspan="1" rowspan="1">160</td><td colspan="1" rowspan="1">5.14</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">160</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-25% Cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">6.76</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">95</td></tr><tr><td colspan="1" rowspan="1">+25% Cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">12.8</td><td colspan="1" rowspan="1">18</td><td colspan="1" rowspan="1">2</td><td colspan="1" rowspan="1">90</td></tr><tr><td colspan="1" rowspan="1">+50% Cutoff</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">15.1</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+75% Cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">17.2</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr></table>

The results summary for Methamphetamine   

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>Drug Concentrationby LC/MS/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay person Results</td><td rowspan=2 colspan=1>The percentageof correctresults (%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>268</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>526</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>769</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1270</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+50% Cutoff</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>1560</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1780</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

The results summary for Methadone

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>Drug Concentrationby LC/MS/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay person Results</td><td rowspan=2 colspan=1>The percentageof correctresults (%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>76.8</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>147</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>226</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>375</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+50%Cutoff</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>441</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>504</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

The results summary for Morphine $( 2 0 0 0 ~ \mathrm { n g / m L } )$   

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>Drug Concentrationby LC/MS/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay person Results</td><td rowspan=2 colspan=1>The percentageof correctresults (%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>535</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>1010</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1580</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>2600</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+50% Cutoff</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>3050</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>3240</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

The results summary for Oxycodone   

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>Drug Concentrationby LC/MS/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay person Results</td><td rowspan=2 colspan=1>The percentageof correctresults (%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>24.5</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>49.3</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>71.1</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>118</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+50%Cutoff</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>147</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>169</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

# The results summary for Phencyclidine

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>Drug Concentrationby LC/MS/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay person Results</td><td rowspan=2 colspan=1>The percentageof correctresults (%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>6.27</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>12.5</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>17.9</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>30.8</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+50%Cutoff</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>36.4</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>42.8</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

The results summary for Marijuana

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>Drug Concentrationby LC/MS/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay person Results</td><td rowspan=2 colspan=1>The percentageof correctresults (%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>13</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>25.3</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>41</td><td rowspan=1 colspan=1>2</td><td rowspan=1 colspan=1>18</td><td rowspan=1 colspan=1>90</td></tr><tr><td rowspan=1 colspan=1>+25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>65</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+50% Cutoff</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>79</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>93</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

The results summary for Oxazepam   

<table><tr><td colspan="1" rowspan="2">% of Cutoff</td><td colspan="1" rowspan="2">Numberofsamples</td><td colspan="1" rowspan="2">Drug Concentrationby LC/MS/MS(ng/mL)</td><td colspan="2" rowspan="1">Lay person Results</td><td colspan="1" rowspan="2">The percentageof correctresults (%)</td></tr><tr><td colspan="1" rowspan="1">No. ofPositive</td><td colspan="1" rowspan="1">No. ofNegative</td></tr><tr><td colspan="1" rowspan="1">-100% Cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-75% Cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">70.8</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-50% Cutoff</td><td colspan="1" rowspan="1">160</td><td colspan="1" rowspan="1">148</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">160</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">-25% Cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">224</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">95</td></tr><tr><td colspan="1" rowspan="1">+25% Cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">390</td><td colspan="1" rowspan="1">19</td><td colspan="1" rowspan="1">1</td><td colspan="1" rowspan="1">95</td></tr><tr><td colspan="1" rowspan="1">+50% Cutoff</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">452</td><td colspan="1" rowspan="1">40</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr><tr><td colspan="1" rowspan="1">+75% Cutoff</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">504</td><td colspan="1" rowspan="1">20</td><td colspan="1" rowspan="1">0</td><td colspan="1" rowspan="1">100</td></tr></table>

The results summary for Methylenedioxy-methamphetamine   

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>Drug Concentrationby LC/MS/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay person Results</td><td rowspan=2 colspan=1>Thepercentage ofcorrect results(%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>137</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>250</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>351</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>600</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+50%Cutoff</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>745</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>925</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

The results summary for Nortriptyline

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>Drug Concentrationby LC/MS/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay person Results</td><td rowspan=2 colspan=1>The percentageof correctresults (%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>273</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>509</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>809</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+25%Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1190</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+50%Cutoff</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>1510</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>1680</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

The results summary for d-Propoxyphene   

<table><tr><td rowspan=2 colspan=1>% of Cutoff</td><td rowspan=2 colspan=1>Numberofsamples</td><td rowspan=2 colspan=1>Drug Concentrationby LC/MS/MS(ng/mL)</td><td rowspan=1 colspan=2>Lay person Results</td><td rowspan=2 colspan=1>The percentageof correctresults (%)</td></tr><tr><td rowspan=1 colspan=1>No. ofPositive</td><td rowspan=1 colspan=1>No. ofNegative</td></tr><tr><td rowspan=1 colspan=1>-100% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>77.4</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-50% Cutoff</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>150</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>160</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>-25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>227</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+25% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>351</td><td rowspan=1 colspan=1>19</td><td rowspan=1 colspan=1>1</td><td rowspan=1 colspan=1>95</td></tr><tr><td rowspan=1 colspan=1>+50% Cutoff</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>420</td><td rowspan=1 colspan=1>40</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr><tr><td rowspan=1 colspan=1>+75% Cutoff</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>492</td><td rowspan=1 colspan=1>20</td><td rowspan=1 colspan=1>0</td><td rowspan=1 colspan=1>100</td></tr></table>

Lay users completed surveys on the ease of understanding the package insert instructions, and the results were found to be acceptable. A Flesch-Kincaid reading analysis on the package insert revealed a reading grade level of less than 7.

2. Matrix Comparison: Not applicable.

# C Clinical Studies:

1. Clinical Sensitivity: Not applicable.

2. Clinical Specificity: Not applicable.

3. Other Clinical Supportive Data (When 1. and 2. Are Not Applicable): Not applicable.

# D Clinical Cut-Off:

# E Expected Values/Reference Range:

# VIII Proposed Labeling:

The labeling supports the finding of substantial equivalence for this device.

# IX Conclusion:

The submitted information in this premarket notification is complete and supports a substantial equivalence decision.